InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Mottola Frank, VP Senior. Director active across 1 company, notably Supernus Pharmaceuticals, INC.. Aggregated, 21 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €160k. History available since 16 February 2023. The latest transaction was disclosed on 12 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Mottola Frank
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
1,650 shares0Common StockSEC:0001804567-26-000014:0
797 shares@ US$46.57Common StockSEC:0001804567-26-000014:1
3,750 shares0Common StockSEC:0001804567-26-000010:0
1,875 shares0Common StockSEC:0001804567-26-000006:0
1,125 shares0Common StockSEC:0001804567-26-000004:0
5,000 shares@ US$39.400.0059% mcap50.0% of flowCommon StockSEC:0001628280-25-058506:0
5,000 shares@ US$39.4020.8% of flowCommon StockSEC:0001804567-25-000006:0
14,000 shares@ US$12.9824.4% of flowCommon StockSEC:0001804567-25-000004:0
2,625 shares0Common StockSEC:0001628280-25-011325:0
337 shares@ US$33.051.6% of flowCommon StockSEC:0001628280-25-010472:0
2,010 shares0Common StockSEC:0001628280-25-008262:0
1,125 shares0Common StockSEC:0001628280-25-007528:0
15,000 shares@ US$9.1319.6% of flowCommon StockSEC:0001628280-24-046668:0
990 shares0Common StockSEC:0001104659-24-029434:0
1,875 shares0Common StockSEC:0001104659-24-028276:0
750 shares0Common StockSEC:0001104659-24-027571:0
2,000 shares@ US$9.242.6% of flowCommon StockSEC:0001104659-23-119162:0
750 shares0Common StockSEC:0001104659-23-044665:0
4,780 shares@ US$35.98824.6% of flowCommon StockSEC:0001104659-23-033366:0
750 shares0Common StockSEC:0001104659-23-025368:0
1,500 shares0Common StockSEC:0001104659-23-023877:0
21 of 21 declarations
About Mottola Frank
Mottola Frank is VP Senior and SVP, Chief Tech. Ops. Officer at Supernus Pharmaceuticals, INC. He has 19 filings in total, and in the sampled recent filings, sales total 160394 EUR over the period from 2023-02-21 to 2026-03-10, with the transaction nature listed as option exercise.
